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Circadian clocks are widespread endogenous mechanisms that
control the temporal pattern of diverse biological processes, in-
cluding gene transcription. KaiA is the positive element of the
cyanobacterial clock because KaiA overexpression elevates tran-
scription levels of clock components. Recently, we showed that the
structure of KaiA is that of a domain-swapped homodimer. The
N-terminal domain is a pseudo-receiver; thus, it is likely to be
involved in signal transduction in the clock-resetting pathway. The
C-terminal domain of KaiA is structurally novel and enhances the
KaiC autokinase activity directly. Here, we report the NMR struc-
ture of the C-terminal domain of KaiA (ThKaiA180C) in complex
with a KaiC-derived peptide from the cyanobacterium Thermosyn-
echococcus elongatus BP-1. The protein–peptide interface is re-
vealed to be different from a model that was proposed earlier, is
stabilized by a combination of hydrophobic and electrostatic in-
teractions, and includes many residues known to produce a circa-
dian-period phenotype upon substitution. Although the structure
of the monomeric subunit of ThKaiA180C is largely unchanged
upon peptide binding, the intersubunit dimerization angle
changes. It is proposed that modulation of the C-terminal KaiA
domain dimerization angle regulates KaiA–KaiC interactions.
Evolutionarily divergent organisms possess mechanisms bywhich biological processes are regulated rhythmically with an
24-h period (1, 2). Such mechanisms, known as circadian
clocks, have been found in multiple eukaryotic groups, including
insects, plants, fungi, and mammals (3), as well as in a single
prokaryotic group, cyanobacteria (4). The cyanobacterial circa-
dian system is potentially the oldest (5) and simplest identified
thus far. Three genes, kaiA, kaiB, and kaiC, are necessary for
rhythmic transcription (4), whereas virtually all promoter ele-
ments of Synechococcus elongatus (PCC 7942), as well as those
introduced from other organisms, are under circadian control (4,
6, 7). The KaiA, KaiB, and KaiC proteins associate in vitro (8)
and in vivo in a circadian-oscillating manner (9), and amino acid
substitutions in these proteins directly affect protein–protein
interactions and the circadian period (4, 10, 11). Light resetting
of the phase of the circadian clock is likely to proceed through
a signal transduction cascade initiated by the sensory protein
CikA (12).
Overexpression of KaiC attenuates global transcription levels
(4, 7). In vitro studies show binding of KaiC to forked DNA (13);
thus, KaiC has been proposed to interact directly with DNA in
vivo and affect transcription levels by global chromatin remod-
eling (14). KaiC shares sequence similarity with the DnaBRecA
bacterial helicase superfamily (15), and recent electron micros-
copy studies show that KaiC forms double ring-shaped hexam-
eric particles in the presence of ATP or nonhydrolysable ATP
analogs (13, 16, 17), with an20-Å-diameter pore present at the
center (13, 17). KaiC has an autokinase activity as demonstrated
in vitro (11, 14, 18) and in vivo (11, 14, 19). The equilibrium
between phosphorylated and unphosphorylated KaiC oscillates
with a circadian pattern (11), and the KaiC autokinase activity
is enhanced by KaiA in vitro (11, 14, 18) and in vivo (11, 14).
Regulation of the KaiC phosphorylation state by means of KaiA
enhancement is believed to be important for the circadian
mechanism (11, 14, 18, 19), yet no details of the KaiA–KaiC
interaction have been available.
We recently showed that KaiA is a two-domain protein with
an N-terminal pseudo-receiver and a structurally novel, KaiC-
interacting C-terminal domain (17, 18). The C-terminal domain
is sufficient to enhance the autokinase activity of KaiC in vitro,
and we proposed (18) that protein–protein interactions at the
N-terminal pseudo-receiver domain of KaiA function in signal-
input to the clock. The putative N-terminal domain protein–
protein interactions are thought to modulate KaiA C-terminal
domain enhancement of the KaiC autokinase activity (18). The
NMR structure of the dimeric C-terminal domain revealed a
likely site for the KaiA–KaiC interaction at the groove between
the two KaiA subunits (17). The recently completed x-ray
structure of full-length KaiA from S. elongatus shows a domain-
swapped homodimer where the N-terminal pseudo-receiver of
one subunit interacts with the C-terminal effector domain of the
other subunit (20). The interdomain interactions are relatively
weak, which led to the hypothesis of two possible KaiA states in
solution, ‘‘closed’’ and ‘‘open,’’ depending on the association or
dissociation of the N- and C-terminal domains (20). In addition,
the x-ray structure of KaiA from Anabaena sp. PCC 7120
(essentially an independent C-terminal KaiA domain) was re-
cently solved (21). Individually, the x-ray structures of the
monomeric subunits of KaiA are virtually identical to the NMR
structures, although the dimerization angle of the C-terminal
domain differs by 20° (20).
Here, we report the identification of a Thermosynechococcus
elongatus BP-1 KaiC-derived peptide (residues 488–518, re-
ferred to as CIIABD) that interacts directly with the C-terminal
domain of T. elongatus KaiA (residues 180–283, referred to as
ThKaiA180C), and we present the NMR structure of the result-
ing 32-kDa complex. CIIABD binding on ThKaiA180C alters
the ThKaiA180C dimerization angle, suggesting that KaiA–KaiC
affinity can be modulated by changes in the dimerization geom-
etry of the KaiA C-terminal domain. We propose that such
changes in quaternary structure occur in vivo to regulate KaiC
autokinase activity enhancement by KaiA and achieve clock-
resetting, possibly by means of interactions of the N-terminal
domain of KaiA with upstream signal transduction proteins (18).
Materials and Methods
Protein Preparation. Details of expression and purification of
ThKaiA180C, as well as preparation of 13C-enriched, unenriched
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heterodimeric ThKaiA180C samples, have been described (17,
22). Segments of the T. elongatus KaiC gene that encode the
desired peptide sequences were cloned in a pET32a vector
(Novagen), thereby creating thioredoxin–polyHis–peptide fu-
sions. The unmodified pET32a-encoded thioredoxin fusion
was used as control peptide for KaiA-binding experiments.
Escherichia coli BL21(DE3) (Novagen) was transformed with
the resulting plasmids and grown in Luria broth or in minimal
medium containing 15N-enriched ammonium chloride and un-
enriched or 13C-enriched glucose (Cambridge Isotope Labora-
tories, Cambridge, MA) as sole nitrogen and carbon sources,
respectively. Expression of peptide fusion constructs was in-
duced by adding isopropyl--D-thiogalactopyranoside (Calbio-
chem) to a final concentration of 1 mM. The cells were harvested
after 4 h, resuspended in a buffer containing 50 mM NaCl and
20 mM TrisCl (pH 7.4), and lysed by heat treatment at 60°C for
15 min. Cell lysates were separated by centrifugation, and the
fusion peptide was purified from the supernatant fraction by
metal affinity chromatography. The sample was buffer ex-
changed to 50 mM NaCl20 mM TrisCl, pH 7.4, and cleaved by
using enterokinase (Novagen). Cleavage by this enzyme results
in the addition of three non-KaiC-derived residues (AMA) at the
N terminus of the peptide. Peptides were isolated by reverse-
phase chromatography and lyophilized. Peptide identity and
purity were confirmed by matrix-assisted laser desorption ion-
ization–time-of-f light spectroscopy, and quantification was car-
ried out by amino acid analysis (Protein Chemistry Laboratory,
Texas A&M University). NMR samples consisted of 1.2 mM
ThKaiA180Cpeptide in a 1:1 molar ratio. NMR buffer condi-
tions were 20 mM NaCl20 mM Na2HPO4, pH 7.07, at 23°C.
NMR Experiments. All experiments were performed at 50°C by
using Inova 600- and 500-MHz spectrometers (Varian) equipped
with triple-axis gradient probes. Sequential 13C, 15N, and 1H-
backbone, side-chain, and stereospecific assignments of
ThKaiA180C were performed as described in refs. 18 and 22.
CIIABD peptide assignments were performed in a similar fashion
by using a sample of uniformly 15N, 13C-enriched CIIABD peptide
and unenriched ThKaiA180C. Interproton nuclear Overhauser
effect (NOE) distance restraints were obtained by 13C, 13C-
edited 4D NOESY (in a sample containing 13C-enriched
ThKaiA180C and unenriched CIIABD peptide), 15N-edited 3D
NOESY (15N-enriched ThKaiA180C and unenriched CIIABD
peptide), 13C-edited, 12C-filtered 3D NOESY (13C-enriched
ThKaiA180C and unenriched CIIABD peptide), 13C-edited, 12C-
filtered 3D NOESY (heterodimeric 13C-enriched, unenriched
ThKaiA180C and 13C-enriched CIIABD peptide), and 13C-
filtered, 13C-edited 3D NOESY (unenriched ThKaiA180C and
13C-enriched CIIABD peptide) spectra. Hydrogen bond restraints
were applied based on hydrogen-exchange protection data col-
lected by NMR, as well as the existence of expected regular
secondary structure NOEs (23). The isomerization state of all
proline residues was determined as trans (23). Backbone dy-
namics measurements (15N T1, 15N T2 and 15N{O1H} NOE)
were performed and analyzed as described in ref. 24. Spectrom-
eter temperature was calibrated by using a methanol sample.
Backbone and side-chain chemical shifts of ThKaiA180C and
CIIABD have been deposited in the BioMagResBank (accession
no. 6174).
NMR Structure Calculations. The  and  dihedral angle values were
derived from the TALOS database (25). For residues for which all
10 predictions lie in the same region of the Ramachandran plot, the
restraint boundaries were set to two SDs. Residues with nine
predictions in the same region of the Ramachandran plot were
restrained within two SDs plus 10°. The X-PLOR-NIH software
package (26) was used for all stages of NMR structure calculations,
which were performed in a manner identical to that described in ref.
17. Noncrystallographic symmetry was enforced between the two
monomeric ThKaiA180C subunits and between the two CIIABD
peptide chains throughout the calculation. However, to better
sample the possible conformations of the intermolecular disulfide
bond (C272 with C272, where prime denotes the second subunit),
C272 of ThKaiA180C was excluded from this symmetry term. In the
final family of structures, this disulphide bridge shows variable
geometry, and therefore, we cannot place it in one of the well
defined classes of disulphide bonds (27). However, the H2/3 and C
C272 resonances show significant broadening in all of the acquired
spectra, indicating that in solution, the geometry of the disulphide
bridge varies on a millisecond–microsecond timescale. The family
of structures consists of the 25 lowest-energy structures that satisfy
all experimental restraints (see Table 1, which is published as
supporting information on the PNAS web site). The structures and
structure-calculation restraints have been deposited in the Protein
Data Bank (accession nos. 1SUY and 1SV1, for the average
minimized structure and the 25-structure ensemble, respectively).
Figure Preparation and Structure Notes. Figures were prepared by
using SPOCK (28). The three N-terminal non-KaiA-derived res-
idues of ThKaiA180C and, similarly, the three N-terminal non-
KaiC-derived residues of CIIABD peptide are not shown.
Results
Identification of a KaiA Binding Site in KaiC. Despite the importance
of KaiA–KaiC interactions in the circadian clock (11), only one
study (29) has focused on identifying the KaiA binding site of
KaiC. Taniguchi et al. (29) were able to locate two different
regions of S. elongatus KaiC, residues 206–263 and 418–519, that
interacted with KaiA in yeast two-hybrid and in vitro coimmo-
bilization assays. From these results, and KaiC structure mod-
eling based on the KaiC–helicase similarity, the authors pre-
dicted that the KaiA–KaiC interaction occurs at the interface
between the predicted CI and CII domains of KaiC (8).
Based on sequence similarity and fold recognition (30), we
expect KaiC to be composed of two RecA-like domains (31),
spanning residues 19–240 and 261–472 of the T. elongatus KaiC
sequence. These domains presumably occupy the two globular
domains observed in the KaiC electron microscopy structures
(13, 16, 17). The highly conserved residues 241–260 (90%
sequence identity between the S. elongatus and T. elongatus
KaiC) constitute a sequence linker between the two RecA-like
domains and probably occupy the physical linker observed in the
KaiC electron microscopy structure (17). The C-terminal resi-
dues 473–518 are highly conserved as well (see Fig. 6, which is
published as supporting information on the PNAS web site). A
small non-RecA-like N-terminal KaiC sequence was not con-
sidered here because of a lack of sequence conservation.
The peptide fragments corresponding to residues 241–260 and
473–518 of T. elongatus KaiC were expressed and purified as
fusions to thioredoxin, as described in Materials and Methods.
Binding to ThKaiA180C was tested by titrating unlabeled KaiC
peptide fusions to 15N-enriched ThKaiA180C with stoichiomet-
ric ratios of 1:1 and by acquiring 1H, 15N heteronuclear single
quantum correlation (HSQC) spectra. No change was observed
in these spectra when the fusion of thioredoxin to KaiC residues
241–260 was used (data not shown). In contrast, the fusion
construct of KaiC residues 473–518 caused dramatic changes in
the 1H, 15N HSQC spectra of ThKaiA180C (see Fig. 7B, which
is published as supporting information on the PNAS web site).
Because no such changes are seen when titrating a control
peptide fusion construct (see Fig. 7C) or the fusion of KaiC
residues 241–260, we attribute this change to a specific interac-
tion of ThKaiA180C with KaiC residues 473–518.
A shorter peptide fragment spanning residues 488–518
(CIIABD; see Fig. 6) with the thioredoxin tag removed was
sufficient to produce similar changes as the larger constructs in
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the ThKaiA180C 1H, 15N HSQC spectra, whereas the quality of
the spectra improved (Figs. 1A and 7B). Constructs with further
N-terminal truncations (spanning residues 496–518) or C-
terminal truncations (residues 488–511) showed decreased bind-
ing, as indicated by the higher stoichiometric ratios that are
necessary to produce a change in the HSQC spectra. CIIABD is
part of the second fragment identified by Taniguchi et al. (29) as
interacting with KaiA, and it includes a site (T495) where an
amino acid substitution is known to induce a clock-period
phenotype (4). An HSQC spectrum of 15N-enriched
ThKaiA180C in complex with CIIABD at a 1:1 ratio is shown in
Fig. 1 A and is compared with an HSQC spectrum of free
ThKaiA180C. Higher ratios of CIIABD to ThKaiA180C did not
produce any further visible changes in the HSQC spectra.
Substoichiometric titrations of CIIABD to ThKaiA180C produce
HSQC spectra with gradual appearance and disappearance of
the bound and free ThKaiA180C resonances, suggesting a slow
timescale of binding. Only one set of resonances is observed in
the 1H, 15N HSQC spectra of bound ThKaiA180C. Therefore,
the complex is symmetric on the NMR timescale, which is
consistent with two CIIABD peptides being bound to a single
ThKaiA180C dimer.
Description of the Structure. The solution structure of the
ThKaiA180C dimer in complex with two CIIABD peptides was
calculated from 2,420 experimental restraints per symmetry unit
(see Table 1) by using the X-PLOR-NIH software package (26). The
ThKaiA180C–CIIABD interface is well defined, with 166 NOE-
derived distance restraints connecting the protein and peptide.
Fig. 1 B–D shows strips from the 13C-edited12C-filtered NOESY
spectra where some of these NOEs are identified. The precision
of the final family of 25 structures (Fig. 2A) was calculated
against the average structure for all ordered residues (defined
residues of ThKaiA180C with 15N{O1H} NOE values 0.6
and CIIABD residues 490–513; see Fig. 8, which is published as
supporting information on the PNAS web site) and is 0.33 0.07
Å for the backbone and 0.76  0.08 Å for heavy atoms of the
ThKaiA180C dimer, and 0.47  0.08 for the backbone and
0.89  0.09 for heavy atoms of the complex (see Table 1).
The overall fold of ThKaiA180C of the complex is that of a
right-turning four-helix bundle (32) with the four -helices
(1–4) organized in two antiparallel helix–loop–helix pairs. The
two helix–loop–helix pairs pack together at a wide angle (50°
on average). As noted in ref. 17, this wide angle of packing is
unusual and places ThKaiA180C in the so-called X-class of
four-helix bundles (33). ThKaiA180C dimerizes along the C-
terminal half of the long 4 helix by using primarily coiled-coil
hydrophobic interactions with 4. Additional hydrophobic in-
teractions, as well as an intersubunit salt bridge and two putative
hydrogen bonds, are formed between 4 and the loop connecting
2 and 3, thereby stabilizing the dimer interface. Four of the
amino acid substitutions of S. elongatus KaiA that are known to
affect clock period can be mapped to identical or chemically
similar residues in the ThKaiA180C hydrophobic core (10, 17),
whereas three substitutions involve residues of the dimer inter-
face. Substitutions of these residues likely destabilize the
ThKaiA180C structure.
The two CIIABD peptides bound to a ThKaiA180C dimer have
an extended L-shaped conformation, as shown in Fig. 2B.
Starting at the N terminus, each peptide chain crosses the wide
angle formed between the helix–loop–helix pairs of one
ThKaiA180C subunit, forms a tight turn, and follows the groove
between the two ThKaiA180C subunits (Figs. 2B and 3). The C
terminus of each peptide chain interacts with the N terminus of
3. Thus, it is clear that KaiA dimerization is necessary for
CIIABD (and presumably KaiC) binding because each peptide
Fig. 1. Observation of ThKaiA180C–CIIABD interactions. (A) The 1H, 15N HSQC spectra of 15N-enriched ThKaiA180C, both free (black) or in a 1:1 complex with
unenriched CIIABD peptide (red). Some of the ThKaiA180C residues that undergo significant chemical shift changes are labeled, and the changes are indicated
by arrows. The residues that experience significant chemical-shift change are at the ThKaiA180C–CIIABD and ThKaiA180C dimerization interfaces. Strips from 3D
13C-edited, 12C-filtered NOESY spectra acquired on 1:1 complexes of 13C-enriched ThKaiA180C and unenriched CIIABD (B and C) and unenriched ThKaiA180C and
13C-enriched CIIABD (D) are also shown. Several NOESY crosspeaks of specific interactions between ThKaiA180C and CIIABD are labeled. *, Crosspeaks with a
maximum in intensity on adjacent 13C planes.








chain makes extensive contacts with both ThKaiA180C subunits.
It is worth noting that the observed arrangement of CIIABD and
ThKaiA180C is different from the hypothesis in ref. 17. Our
earlier model predicted that a KaiC-derived peptide would
interact with ThKaiA180C by passing through the groove be-
tween the ThKaiA180C subunits. Instead, CIIABD lies along that
groove. Further, CIIABD binding completely occludes the
groove, as indicated by accessible surface area calculations of the
entire complex (data not shown). Thus, we expect that additional
KaiC interactions inside the ThKaiA180C groove are unlikely.
The two symmetry-related CIIABD peptides could correspond to
two KaiC molecules of the same hexameric KaiC particle or,
alternatively, to two different hexameric KaiC particles in close
proximity.
Description of the ThKaiA180C–CIIABD Interface. CIIABD forms a
combination of hydrophobic, electrostatic, and hydrogen bond-
ing interactions with ThKaiA180C (see Fig. 6) that result in
burial of 1,400 Å2 per peptide unit. An accessible surface area
representation of ThKaiA180C, with the surface of hydrophobic
side chains shown in gold, is shown in Fig. 3. The peptide
(purple) lies along a series of mostly conserved hydrophobic
patches created by the L202, F205, F243, I256, L258, L262, I265,
L233, V237, and L257 residues of ThKaiA180C (see Fig. 6). A
total of eight hydrophobic side chains anchor CIIABD to that
surface (I490, T493, T495, V499, L505, A506, I508, and M512).
Several electrostatic interactions between ThKaiA180C and
CIIABD can be inferred from the structure. Charge–charge
interactions are seen between D500 of CIIABD and K248 of
ThKaiA180C: E501 with K248, K502 with D241, K502 with
E238, and K510 with D266. Also, a large number of putative
hydrogen bonds between ThKaiA180C and CIIABD can be seen
in many structures of the ensemble, which would increase the
specificity of interaction. These hydrogen bonds occur between
the C and N of I490 of CIIABD and O1 and N2 of Q246 of
ThKaiA180C, respectively, as well as between C of P494 and N
of R252; N and O1 of T495 with C and N of S253; N2 of R496
and C of F205; O1 and O2 of E501 and C and O of S244;
N of K510 and N	1 of H270; S	 of M511 and O2 of E273; and
N2 of Q513 and O1 of E234.
The importance of this peptide–protein interface for the
correct function of the circadian clock is demonstrated by the
significant number of clock-period phenotype amino acid sub-
stitutions that can be mapped here (4, 10). Six known substitu-
tions are mapped to E238, D241, F243, S244, K248, and E273 of
ThKaiA180C, which are residues that provide important inter-
actions for peptide binding as revealed by the structure (see Fig.
6). A seventh ThKaiA180C amino acid with a clock-period
phenotype substitution, T242, is placed near the flexible N
terminus of CIIABD and is possibly implicated in full-length KaiC
binding. In CIIABD, T495 is responsible for important hydro-
phobic and putative hydrogen bonding interactions to
ThKaiA180C (see Fig. 6). The NMR structure suggests that
substitution of these residues is likely to weaken the KaiA–KaiC
interaction, thereby causing the observed lengthening of the
clock period (4, 10).
Comparison of Free and Bound ThKaiA180C. The ThKaiA180C
monomeric subunit is relatively unchanged upon CIIABD binding
and maintains the unusually wide angle of packing between the
two helical pairs (50° in the bound and free forms) (17). The
backbone rms deviation of the average minimized structures of
free and bound ThKaiA180C is 1.27 Å over all ordered residues
Fig. 2. Structure of the ThKaiA180C–CIIABD complex. Shown are the overlaid backbones of the 25-structure ensemble (PDB ID code 1SV1) (A) and the average
minimized structure (PDB ID code 1SUY) in two mutually orthogonal views (B). ThKaiA180C backbones are shown in gold, and CIIABD is shown in blue.
Fig. 3. Hydrophobic interactions in the ThKaiA180C–CIIABD complex. An
accessible surface area representation of ThKaiA180C is shown, with the area
of exposed hydrophobic side chains shown in gold. CIIABD (purple) is anchored
mainly on a series of hydrophobic patches through mostly conserved nonpolar
residues (labeled). The CIIABD N and C termini are indicated.
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(inclusive, 187–208, 212–247, and 258–279) (17). The most
important differences occur at the C-terminal part of 3 and the
N-terminal part of 4, where CIIABD makes several contacts.
Exclusion of that region (ThKaiA180C residues 241–247 and
258–260) improves the superposition to 0.94 Å. This case is
shown in Fig. 4A.
The biggest change between free and bound ThKaiA180C is
in the angle of dimerization. As shown in Fig. 4B, when the
monomeric subunits of ThKaiA180C are superimposed, the
second monomeric subunits show a relative rotation around
the dimerization interface. This rotation is driven by insertion of
CIIABD nonpolar side chains (L505 and A506) in the
ThKaiA180C dimerization groove, where they form a hydro-
phobic cluster with side chains of residues at or near the
ThKaiA180C dimerization interface (L233, H236, L264, and
I265). A total of eight NOESY crosspeaks were unambiguously
identified from the 13C-edited, 12C-filtered NOESY spectra as
connecting this cluster. In addition, ThKaiA180C residues at or
near the dimer interface (I227, Y275, and I279), but relatively far
in space from the ThKaiA180C–CIIABD interactions also show
significant shifts in the 1H, 15N HSQC spectra upon CIIABD
binding (Fig. 1 A), which also suggests changes of the quaternary
dimer structure.
Discussion
The ThKaiA180C–CIIABD complex structure discussed here
provides structural explanations for earlier mutant phenotypes
(4, 10). It is important to note that the changes observed in the
quaternary structure of the ThKaiA180C dimer upon binding
CIIABD should be bidirectional; i.e., protein–KaiA interactions
that influence the dimerization angle of the C-terminal domain
of KaiA will thereby also alter the affinity of KaiA for KaiC.
Thus, we propose that protein–protein interactions at the N-
terminal pseudo-receiver domain of KaiA, possibly from a signal
cascade originating at the sensory protein CikA (12), alter the
dimerization angle of the C-terminal domain of KaiA. In this
way, the KaiA–KaiC affinity and KaiA enhancement of the KaiC
autokinase activity can be regulated, and the clock can be reset
in response to environmental stimuli (Fig. 5). KaiA proteins
from filamentous cyanobacteria, such as Anabaena sp. PCC 7120
and Nostoc punctiforme, do not include an N-terminal pseudo-
receiver domain (18). It is possible that in these cases the putative
signal cascade directly interacts with the KaiA C-terminal do-
main and suggests differences in the circadian clock resetting
mechanism between filamentous and nonfilamentous cyanobac-
terial species. Previous KaiC autokinase activity assays show that
full-length KaiA stimulates KaiC phosphorylation to a higher
extent than the C terminus of KaiA alone (18). These results can
be interpreted by our proposal because the dimerization angle
was found to be different between the full-length KaiA structure
and that of the free C-terminal KaiA domain in solution (20).
However, the quaternary structural differences observed be-
tween the crystal and solution structures could also be induced
by packing forces in the crystal.
Previous models of Kai protein complex formation can also be
analyzed based on our results. Ye et al. (20) proposed a model
in which the KaiA–KaiC interaction drives KaiA in a hypothe-
sized open conformation that has high affinity for KaiB. Our
results show that KaiC binding indeed changes the quaternary
structure of the C-terminal KaiA domain. We expect that these
Fig. 4. Comparison of the structures of C-terminal KaiA domains. Shown
here are the backbone representations of free ThKaiA180C (red) (17) and
ThKaiA180C when in complex with CIIABD (gold). The N and C termini of chains
are indicated. The monomeric subunits of the two domains are superimposed
and shown in A. The backbone rms deviation is 0.94 Å for free vs. bound
ThKaiA180C. (B) Superpositions of one of the subunits shows differing rota-
tions around the dimerization interface of the second subunits. (For clarity,
the superimposed subunits are not shown.)
Fig. 5. Putative mechanism for clock resetting. An upstream signal cascade,
possibly originating from CikA (12), interacts with the N-terminal domain of
KaiA and alters the quaternary dimer structure of the C-terminal domain.
Changes in the dimerization angle of the KaiA C-terminal domain change its
affinity for KaiC and, thus, change the KaiA-induced KaiC autokinase activity
enhancement and affect the KaiC phosphorylation equilibrium. Perturbations
in the KaiC phosphorylation equilibrium alter the circadian oscillator and
possibly cause resetting.








changes can also influence the relative conformation of the two
KaiA domains, possibly in a manner similar to that suggested by
Ye et al. (20). Garces et al. (21) have proposed a different model
of how KaiB may attenuate KaiA enhancement of KaiC phos-
phorylation, in which KaiA and KaiB use a similar concave
surface (corresponding to the surface at the bottom of the KaiA
particle, as shown in Fig. 3) for KaiC binding and, thus, compete
for KaiC. However, the surface proposed earlier for KaiA (21)
as interacting with CIIABD is perpendicular to that found here.
Further, in the orientation proposed by Garces et al., KaiB does
not feature the largely hydrophobic groove used by CIIABD for
KaiA binding. Thus, our structural data do not provide evidence
for competition between KaiA and KaiB for CIIABD binding.
It is important to note that earlier studies showed KaiA
binding to both CI and CII subunit of KaiC by using in vitro or
yeast two-hybrid assays (8, 29), yet no sequence homologous to
CIIABD exists in CI. Thus, it is possible that an additional,
different, KaiA-interacting fragment is present in CI. However,
the ThKaiA180C–CIIABD interaction described here is extensive
and can account for all of the KaiA C-terminal domain solvent
exposed amino acid substitutions with a clock-period phenotype
(4, 10). Therefore, we believe that interactions of KaiA with CI
are secondary to those with the CII domain of KaiC, although
it is likely that they will contribute to the specificity and affinity
of the KaiA–KaiC complex. The stoichiometry of the
ThKaiA180C–CIIABD complex is likely to be physiologically
relevant. KaiC abundance in vivo is relatively high compared
with KaiA (19), and therefore, we expect that a KaiA dimer will
be bound to two KaiC protein molecules for at least some
fraction of the circadian period. However, KaiA can fully
enhance the KaiC autokinase activity even at relatively low
KaiAKaiC stoichiometries (34), suggesting that formation of
the KaiA–KaiC complex is transient. Currently, it is not known
whether the KaiC autokinase activity operates as cis or trans
(transphosphorylation). Because a KaiA dimer can bind simul-
taneously to two KaiC-derived peptides, which could correspond
to independent KaiC hexamers, it is conceivable that KaiA
enhances KaiC autophosphorylation by acting as a linker module
that temporarily brings together two different KaiC hexamers in
order for transphosphorylation to occur.
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